access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast
Image of liver cells

Analytical Cell Models Core

The goal of this Core is to generate cells for DDRC members to study diseases of the liver and gastrointestinal tract. This is a matrix style Core that leverages existing resources on the MUSC campus (cytometry, CyTOF, drug discovery, and cell isolation). The Core provides new services for DDRC investigators who use rodent liver cells and human induced pluripotent stem cells  (iPSCs). These services fall in line with the theme of the DDRC and with the expertise of the Center’s members. The Core provides hepatocytes, sinusoidal endothelial cells, Kupffer cells and hepatic stellate cells to investigators who wish to study either normal cells or cells from injured mouse or rat livers.

The Core also uses genome engineering to introduce specific genetic mutations associated with digestive disease into both established cell lines and pluripotent stem cells. Established cell lines harboring genetic variations can be used to test the investigator’s hypotheses directly. Pluripotent stem cells will be induced to differentiate into liver or gut cells, and tissue biopsies from patients is used for the generation of gut and liver organoids. Differentiated cells are distributed as needed by the core.

The Core also offers a suite of analytical tools to facilitate the members’ study of cell models and to identify novel treatments for digestive disease. These tools include advanced cytometry and drug discovery platforms. To expand the DDRC members’ technology portfolios, we also provide researchers with hands-on training, validated reagents, as well as ongoing access to core expertise, which is consistently updated to incorporate advances in the field.

Core Leader:

Stephen A. Duncan, DPhil